Catalyst Wire Dossier Catalyst Wire Dossier

Respimat Budesonide

Budesonide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Respimat Budesonide, covering 2014-07-18 to 2014-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy [Phase 3]

See pricing